Business
Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform
Alvogen Pharma US, Inc. ("Alvogen"), a privately owned US-based pharmaceutical company, today announced a definitive agreement by its shareholders to sell its parent company to Lotus Pharmaceutical Co., Ltd. ("Lotus", TWSE: 1795). Under the terms of the agreement, Alvogen will become a controlled subsidiary of Lotus, subject to customary closing conditions.
About this update from Lotus Pharmaceutical Co., Ltd.
[{"type":"text","content":"MORRISTOWN, N.J., Sept. 23, 2025 /PRNewswire/ -- Alvogen Pharma US, Inc. ("Alvogen"), a privately owned US-based pharmaceutical company, today announced a definitive agreement by its shareholders to sell its parent company to Lotus Pharmaceutical Co., Ltd. ("Lotus", TWSE: 1795). Under the terms of the agreement, Alvogen will become a controlled subsidiary of Lotus, subject to customary closing conditions.","length":428,"tagName":"p"},{"type":"image","alt":"Alvogen Pharma US, Inc. (PRNewsfoto/Alvogen Pharma US, Inc.)","displaySize":"","headline":null,"caption":"Alvogen Pharma US, Inc. (PRNewsfoto/Alvogen Pharma US, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":125,"url":"https://media.zenfs.com/en/prnewswire.com/111073da4753b2d7a0977ece09805d2c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZsxLA.Buzsv2EgZZk2Vhyw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/111073da4753b2d7a0977ece09805d2c","width":400,"height":125}},"href":"https://mma.prnewswire.com/media/2637074/Alvogen_Pharma_US_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The agreement builds upon the existing long-standing collaboration between Alvogen and Lotus including several highly successful co-developed product launches, and gives Lotus access to a U.S. platform including a dedicated salesforce, in-house manufacturing at Alvogen's Norwich, New York facility, and a complementary R&D pipeline.","length":341,"tagName":"p"},{"type":"text","content":""This acquisition represents a culmination of Alvogen's operational excellence and targeted portfolio aimed at sustainable growth. Joining Lotus positions Alvogen for its next stage of expansion into multiple segments. With Lotus' global partnerships and APAC distribution, we expect to extend the reach of our specialized generics and brands while maintaining our commitment to quality and reliable supply from our Norwich facility," said Lisa Graver, Chief Executive Officer, Alvogen.","length":509,"tagName":"p"},{"type":"text","content":"Robert Wessman, Chairman of Alvogen and Lotus, added: "We are excited to combine Alvogen with Lotus Pharmaceutical. This acquisition represents a natural evolution of our long-standing partnership and provides o...